These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21920264)

  • 1. Botero's fat figures and the risk of heart failure.
    Hsich E
    J Am Coll Cardiol; 2011 Sep; 58(13):1351-2. PubMed ID: 21920264
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
    Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
    J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome in Heart Failure: Friend or Foe?
    Arcopinto M; Schiavo A; Salzano A; Bossone E; D'Assante R; Marsico F; Demelo-Rodriguez P; Baliga RR; Cittadini A; Marra AM
    Heart Fail Clin; 2019 Jul; 15(3):349-358. PubMed ID: 31079693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity.
    Ferrari F; Facchinetti F; Ontiveros AE; Roberts RP; Saade MM; Blackwell SC; Sibai BM; Refuerzo JS; Longo M
    Am J Obstet Gynecol; 2016 Oct; 215(4):503.e1-8. PubMed ID: 27255472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, insulin resistance and the metabolic syndrome.
    Sinaiko A
    J Pediatr (Rio J); 2007; 83(1):3-4. PubMed ID: 17279288
    [No Abstract]   [Full Text] [Related]  

  • 6. Why a cluster is truly a cluster: insulin resistance and cardiovascular disease.
    Reaven G
    Clin Chem; 2008 May; 54(5):785-7. PubMed ID: 18375479
    [No Abstract]   [Full Text] [Related]  

  • 7. A possible role of cystatin C in adipose tissue homeostasis may impact kidney function estimation in metabolic syndrome.
    de Vries AP; Rabelink TJ
    Nephrol Dial Transplant; 2013 Jul; 28(7):1628-30. PubMed ID: 23262435
    [No Abstract]   [Full Text] [Related]  

  • 8. Female offspring born to obese and insulin-resistant dams are not at increased risk for obesity and metabolic dysfunction during early development.
    Aburasayn H; Al Batran R; Gopal K; Almutairi M; Eshreif A; Eaton F; Ussher JR
    Can J Physiol Pharmacol; 2018 Jan; 96(1):97-102. PubMed ID: 28886253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rs1501299 Polymorphism in the Adiponectin Gene and Their Association with Total Adiponectin Levels, Insulin Resistance and Metabolic Syndrome in Obese Subjects.
    de Luis DA; Izaola O; de la Fuente B; Primo D; Fernandez Ovalle H; Romero E
    Ann Nutr Metab; 2016; 69(3-4):226-231. PubMed ID: 27915341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity.
    de Luis DA; Izaola O; de la Fuente B; Primo D; Aller R
    J Nutrigenet Nutrigenomics; 2016; 9(5-6):213-221. PubMed ID: 27788523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic biomarkers and gallstone disease - a population-based study.
    Shabanzadeh DM; Skaaby T; Sørensen LT; Eugen-Olsen J; Jørgensen T
    Scand J Gastroenterol; 2017 Nov; 52(11):1270-1277. PubMed ID: 28799434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract.
    Feakins RM
    Histopathology; 2016 Apr; 68(5):630-40. PubMed ID: 26599607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects.
    Nestel P; Hoang A; Sviridov D; Straznicky N
    Int J Obes (Lond); 2012 Mar; 36(3):407-13. PubMed ID: 21876547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin tags: a useful clinical sign for insulin resistance?
    Crook M
    Eur J Dermatol; 2012; 22(1):5-6. PubMed ID: 22237167
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaesthetic considerations with the metabolic syndrome.
    Tung A
    Br J Anaesth; 2010 Dec; 105 Suppl 1():i24-33. PubMed ID: 21148652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between Measures of Fitness and Metabolic Health in Treatment-Seeking Youth with Obesity.
    Guseman EH; Cauffman SP; Tucker JM; Smith L; Eisenmann JC; Stratbucker W
    Metab Syndr Relat Disord; 2017 Apr; 15(3):107-111. PubMed ID: 27869528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease: A sign of systemic disease.
    Reccia I; Kumar J; Akladios C; Virdis F; Pai M; Habib N; Spalding D
    Metabolism; 2017 Jul; 72():94-108. PubMed ID: 28641788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Glycemic Variability and Inflammatory Markers in Obese Children with Insulin Resistance and Metabolic Syndrome.
    Kaya A; Koçyiğit C; Çatlı G; Özkan EB; Dündar BN
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):202-207. PubMed ID: 28163257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.